Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
J. Gobbo,Guillaume Marcion,16 Authors,C. Garrido
2016 · DOI: 10.1093/jnci/djv330
Journal of the National Cancer Institute · 179 Citations
TLDR
A8 might be useful for quantifying tumor-derived exosomes and for cancer therapy through MDSC inhibition and the antitumor effect of the drugs was strongly potentiated.